Literature DB >> 34349550

Adapting Diabetes Risk Scores for Jordan.

Amjad Al Shdaifat1, Yousef Khader2, Muwafag Al Hyari3, Omar Shatnawi1, Mus'ab Banat1.   

Abstract

BACKGROUND: Diabetes risk score can be used as a simple non-invasive screening tool for identifying people with high risk of diabetes. This study aimed to assess the predictive power of various risk-scoring systems to predict pre-diabetes and diabetes in Jordanian adults.
METHODS: This cross-sectional study was conducted among people attending 54 primary health care centers distributed throughout the 12 governorates of Jordan. Diabetes risk scores using the American Diabetes Association risk score, Canadian risk score, Finland risk score (FINDRISC), British Risk score, German and Australian risk score were calculated for each patient. Fasting blood sugar (FBS) was measured for all participants.
RESULTS: This study included 392 participants: 231 patients with normal fasting blood sugar (FBG), 101 patients with pre-diabetes and 60 patients with type 2 diabetes. The FINDRISC, British, and Australian risk scores were strongly inter-correlated and weakly correlated with other systems' risk scores. Moreover, they correlated moderately and significantly with FBS. In contrast, other systems risk scores were associated weekly with FBS. Based on receiving operating characteristics (ROC) analysis and multivariate logistic regression, the FINDRISC risk score was superior to other risk scores to predict high FBS and identify pre-diabetes and diabetes.
CONCLUSION: FINDRISC risk score performed the best compared to other risk scores for predicting pre-diabetes, diabetes, and absence of diabetes. We recommend using the FINDRISC risk score assessment in Jordan.
© 2021 Shdaifat et al.

Entities:  

Keywords:  ADA risk score; Canadian risk score; FINDRISC risk score; German risk score; Jordan; diabetes

Year:  2021        PMID: 34349550      PMCID: PMC8326934          DOI: 10.2147/IJGM.S321063

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


Introduction

Type 2 diabetes mellitus (T2DM) is a metabolic disease associated with increased morbidity and mortality mainly because of increased cardiovascular risk.1,2 The overall age-standardized prevalence rate of diabetes increased from 13.0% in 1994 to 17.1% in 2004, 22.2% in 2009 and 23.7% in 2017.3,4 There are many risk factors for developing diabetes. The impact of each of these risk factors differs from nation to nation depending on various variables, including ethnicity, age, sex, family history, sedentary lifestyle, type of food, smoking, coffee consumption, and other factors.5 Various risk scores to predict diabetes were developed worldwide. The most common risk scores include the American Diabetes Association risk score, Canadian risk score, Finland risk score (FINDRISC), British risk score, German and Australian risk score.6–11 A strong argument exists in favor of screening for subjects who are at increased risk for diabetes. Screening helps recognize people at high risk for diabetes as well as patients with undiagnosed diabetes. Those people need lifestyle modification including adequate physical activity and healthy diet consumption to prevent or delay diabetes and its complications.6 As the prevalence of diabetes increases in the Middle East and Jordan, it is imperative either to create a new Jordanian risk score or adopt the most suitable international risk score to predict DM for use in Jordan. Risk scores can be used as a simple non-invasive screening tool for diabetes in order to find high-risk individuals who can then take protective measures to prevent or delay DM by improving modifiable risk factors and arranging to for regular blood glucose testing.12 This study aimed to assess the predictive power of various risk-scoring systems to predict pre-diabetes and diabetes in Jordanian adults.

Materials and Methods

Study Setting and Participants

This cross-sectional study was conducted among people attending 54 primary health care centers distributed throughout the 12 governorates of Jordan. Centers were selected randomly using simple random sampling technique. Within each center, participants who met the inclusion criteria were recruited consecutively. Those who agreed to participate were informed about the purpose of the study and signed the informed consent. Only adults above 18 years old were included in this study. Known cases of diabetes or females with a history of gestational diabetes were excluded. The study was approved by the institutional review board (IRB) committee at Hashemite University. And all participants were informed about the purpose of the study, and that it was conducted in accordance with the Declaration of Helsinki.

Data Collection

Data collection took 3 months from mid June 2019 to mid-September 2019. We selected the most commonly used risk scores for diabetes in the world for use in our study: American Diabetes Association risk score, Canadian risk score, Finland risk score (FINDRISC), British Risk score, German and Australian risk score. For each patient, a risk score was calculated by each method. A structured questionnaire was used to collect the data including demographic data. After completing the questionnaire, each participant had their height measured to the nearest 1 cm with participants standing without shoes using a wall-fixed scaled meter. The weight was measured to the nearest 1 kg with minimal clothing and without shoes using a portable electronic scale.

Blood Tests

All participants had their fasting blood sugar measured either on the same day of visit or the next day. If the patient was not fasting and could not return the next day, they were excluded from the study. A second confirmatory test was done for those with high reading (≥126) to confirm diagnoses.

Statistical Analysis

Statistical analysis was conducted with IBM SPSS 24 (IBM Corp. Released 2016. IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp.). Mean and standard deviation were used to describe continuous variables. Frequencies and percentages were used to describe categorical variables. Participants were categorized into three groups according to their FBS levels: Normal, prediabetes, and diabetes. The participants’ characteristics were compared among groups using Chi-square test. The differences in the mean risk scores of different systems were compared using One Way ANOVA. The normality assumption was checked graphically using the histogram. The proportions of participants with high-risk scores according to different scoring systems were compared between the three groups using Chi-square test. Pearson’s correlation coefficient was used to assess the correlation between scores of studied scoring systems. Area Under Curve (AUC) was calculated for each scoring system using Receiving Operating Characteristics (ROC) curve to assess the predictability of high-risk score to predict FBG>100, prediabetes, and diabetes. AUC 0.7 to 0.8 is considered acceptable, 0.8 to 0.9 is considered excellent, and more than 0.9 is considered outstanding. Separate binary logistic regression models were conducted to determine the association between high-risk scores of different scoring systems (independent variables) and the studies outcomes including FBG>100, prediabetes, and diabetes (dependent variables). The sensitivity, specificity, predictive value positive, predictive value negative and accuracy of high-risk scores of different scoring systems were calculated for the FBS>100, pre-diabetes, and diabetes. A p-value of 0.05 or less was considered to indicate statistical significance.

Results

This study included 392 participants. Of those, 231 persons had normal FBG, 101 persons had pre-diabetes, and 60 persons had type 2 diabetes mellitus. More than half of participants (57.9%) were females, 50.3% aged more than 40 year, and 65.6% were either overweight or obese. Table 1 shows the demographic and anthropometric characteristics of participants according to diabetes status. The distribution of sex, age, and BMI differed significantly between people according to FBS categories.
Table 1

Shows the Demographic and Anthropometric Characteristics of Participants According to Diabetes Status

VariableTotal N = 392Normal (n = 231)Prediabetes (n = 101)Diabetes (n = 60)P-value (Chi-Square Test)
N%n%n%n%
Sex<0.001
 Male16542.17733.35756.43151.7
 Female22757.915466.74443.62948.3
Age0.001
 17–308321.26628.61514.923.3
 31–4011228.68436.42322.858.3
 41–507819.93816.52423.81626.7
 >5011930.44318.63938.63761.7
Body Mass Index0.001
 Normal13534.410344.62120.81118.3
 Overweight12331.47231.23029.72135.0
 Obesity13434.25624.25049.52846.7
Shows the Demographic and Anthropometric Characteristics of Participants According to Diabetes Status The FINDRISC, British, and Australian risk scores were strongly inter-correlated and weakly correlated with other systems’ risk scores (Table 2). The FINDRISC, British, and Australian risk scores correlated moderately and significantly with FBS. In contrast, other systems risk scores were associated weekly with FBS.
Table 2

Inter-Correlations Between Different Risk Score Systems and Their Correlation with Fasting Blood Sugar

FBSFINDRISCBritish ScoreAustralianCanadianGermanADA
FBS1.00
FINDRISC0.491**1.00
British score0.323**0.820**1.00
Australian0.482**0.873**0.871**1.00
Canadian0.060.030.090.081.00
German−0.05−0.010.000.00−0.509**1.00
ADA−0.060.01−0.03−0.030.07−0.011.00

Notes: **Pearson’s correlation coefficient. P-value < 0.01.

Inter-Correlations Between Different Risk Score Systems and Their Correlation with Fasting Blood Sugar Notes: **Pearson’s correlation coefficient. P-value < 0.01. Table 3 shows the mean risk score using different scoring systems according to diabetes status. The means of risk score for FINDRISC, British, Australian, and Canadian scoring systems were significantly higher among patients with pre-diabetes and patients with type 2 diabetes. The mean risk score using the German scoring system was the highest among people with normal FBG. According to the FINDRISC, British, and Australian risk score, the proportion of participants with high-risk scores was significantly higher among patients with prediabetes and patients with type 2 diabetes than those with normal FBG (Table 4).
Table 3

The Differences in Risk Scores According to Diabetes Status

Scoring SystemNormal (n = 231)Prediabetes (n = 101)Diabetes (n = 60)P-value (ANOVA)
MeanSDMeanSDMeanSD
FINDRISC7.74.012.14.615.44.10.000
British score16.98.023.57.926.79.70.000
Australian12.56.220.17.725.56.90.000
Canadian10.54.812.05.011.54.40.028
German51.617.145.917.550.119.20.024
ADA3.92.33.62.13.62.40.506
Table 4

The Proportion of Participants with High Risk Scores According to Diabetes Status

Scoring SystemNormal (n = 231)Pre-Diabetes (n = 101)Diabetes (n = 60)P-value (Chi-Square test)
Nnn
FINDRISC135.63029.73965.0<0.001
British4820.84746.53660.0<0.001
Australian11449.48584.25795.0<0.001
Canadian4720.32928.71321.70.241
German9340.33130.72338.30.251
ADA9440.73736.62135.00.633
The Differences in Risk Scores According to Diabetes Status The Proportion of Participants with High Risk Scores According to Diabetes Status According to AUC, the FINDRISC risk score and Australian risk score performance were excellent for predicting FBG>100 and diabetes and acceptable for predicting pre-diabetes (Table 5). The British risk score’s performance to predict FBG>100, pre-diabetes, and diabetes was acceptable The predictability power of other scoring systems was less than adequate.
Table 5

The Predictability of High Risk Score Using Different Scoring System to Predict FBG>100, Pre-Diabetes, and Diabetes Using Receiving Operating Characteristics (ROC)

Scoring SystemArea Under the Receiving Operating Characteristics (ROC) Curve (AUC)*
FBG>100PrediabetesFBG>126
Finnish risk score0.8160.7630.844
British score0.7480.7300.725
Australian risk score0.8280.7820.844
Canadian risk score0.5740.5870.524
German risk score0.4290.4080.491
ADA risk score0.4640.4670.469

Notes: *AUC 0.7 to 0.8 is considered acceptable, 0.8 to 0.9 is considered excellent, and more than 0.9 is considered outstanding.

The Predictability of High Risk Score Using Different Scoring System to Predict FBG>100, Pre-Diabetes, and Diabetes Using Receiving Operating Characteristics (ROC) Notes: *AUC 0.7 to 0.8 is considered acceptable, 0.8 to 0.9 is considered excellent, and more than 0.9 is considered outstanding. In the multivariate analysis, only the high-risk scores using FINDRISC, British, and Australian scoring systems were significantly associated with FBS>100, pre-diabetes, and diabetes. According to odds ratios, the FINDRISC high-risk score is superior to other systems’ high-risk scores to predict pre-diabetes and diabetes. The sensitivity, specificity, predictive value positive, predictive value negative and accuracy of high-risk scores of different scoring systems to predict FGS>100, pre-diabetes, and diabetes are shown in Table 6.
Table 6

The Predictability of High Risk Score Using Different Scoring System to Predict FBG>100, Pre-Diabetes, and Diabetes Using Binary Logistic Regression Analysis*

Sensitivity (%)Specificity (%)Predictive Value + (%)Predictive Value – (%)Accuracy (%)Binary Logistic Regression Analysis
OR95% CIP-value
FBG>100
 Finnish risk score45.593.279.374.875.812.66.623.90.000
 British score53.177.958.074.368.94.12.66.30.000
 Australian risk score90.249.050.489.764.07.74.513.20.000
 Canadian risk score25.278.740.464.759.21.40.92.20.183
 German risk score34.360.633.361.651.00.70.51.10.177
 ADA risk score34.358.632.260.849.70.80.51.20.351
FBG>126
 Finnish risk score66.187.147.693.583.912.56.723.20.000
 British score61.071.527.591.269.93.72.16.60.000
 Australian risk score94.939.921.997.848.212.73.941.40.000
 Canadian risk score22.077.214.684.868.90.90.51.80.835
 German risk score39.062.815.685.359.21.00.61.80.885
 ADA risk score35.660.713.884.256.90.80.51.50.515
Pre-diabetes
 Finnish risk score59.691.368.387.783.77.13.514.30.000
 British score58.574.542.085.170.73.32.05.50.000
 Australian risk score95.744.335.297.156.65.53.09.90.000
 Canadian risk score23.477.524.776.264.51.60.92.70.097
 German risk score33.061.121.174.354.30.70.41.10.098
 ADA risk score33.059.420.473.853.10.80.51.40.487

Notes: *High-risk scores of different scoring systems were treated as predictors in the multivariate analysis after adjusting for gender and age and.

The Predictability of High Risk Score Using Different Scoring System to Predict FBG>100, Pre-Diabetes, and Diabetes Using Binary Logistic Regression Analysis* Notes: *High-risk scores of different scoring systems were treated as predictors in the multivariate analysis after adjusting for gender and age and.

Discussion

Recent studies have shown that type 2 diabetes can be prevented in high-risk subjects with impaired glucose tolerance by lifestyle interventions.13,14 Measuring diabetes scores is both simple and important. Several trials showed that a healthy lifestyle with weight loss and physical activity (PA) decreases short and long-term risk for individuals with impaired glucose tolerance.14,15 There are many validated risk scores for diabetes worldwide. The risk for diabetes differs from one country to another according to lifestyle, type of food, exercise, and ethnicity. For this reason, each country must have developed its own risk score or at least find the best risk score for its population. This is the first study in Jordan to assess diabetes risk scores in Jordan. This study highlights the magnitude of the problem since diabetes is increasing dramatically. Because of the COVID-19 pandemic, it is expected that the prevalence of NCD will increase due to lockdowns, closure of sports clubs, and limitation of movements.5,16 Our study utilized many popular risk scores for non-diabetic patients. Blood sugar was measured for these patients and compared with the risk scores calculated in order to find which risk score best predicted increased blood sugar. The results showed that 15.3% of the patients had previously undiagnosed diabetes and 25% had prediabetes. This emphasizes the need for risk score measurement for all health center visitors and blood sugar measurement for high-risk individuals according to risk score screening. The study statistics showed that the FINDRISC risk score is the best score for predicting prediabetes and diabetes. Therefore, we recommend using the FINDRISC risk score in Jordan in all health centers to screen for diabetes. Furthermore, all screened individuals with high and very high risk should have a fasting blood sugar test performed. This result corresponds with many studies that showed the superiority of FINDRISC risk score in many countries. The main limitation of this study is inherited in its cross-sectional design. A longitude study would be more appropriate to assess the predictability of different risk scores.

Conclusion

FINDRISC risk score performed the best compared to other risk scores for predicting prediabetes, diabetes, and absence of diabetes. We recommend using the FINDRISC risk score assessment in Jordan.
  11 in total

1.  Time trends in diabetes mellitus in Jordan between 1994 and 2017.

Authors:  K Ajlouni; A Batieha; H Jaddou; Y Khader; N Abdo; M El-Khateeb; D Hyassat; D Al-Louzi
Journal:  Diabet Med       Date:  2019-01-25       Impact factor: 4.359

2.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

3.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

4.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

5.  Update of the German Diabetes Risk Score and external validation in the German MONICA/KORA study.

Authors:  Kristin Mühlenbruch; Tonia Ludwig; Charlotte Jeppesen; Hans-Georg Joost; Wolfgang Rathmann; Christine Meisinger; Annette Peters; Heiner Boeing; Barbara Thorand; Matthias B Schulze
Journal:  Diabetes Res Clin Pract       Date:  2014-03-28       Impact factor: 5.602

6.  Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters.

Authors:  Jamie Hartmann-Boyce; Elizabeth Morris; Clare Goyder; Jade Kinton; James Perring; David Nunan; Kamal Mahtani; John B Buse; Stefano Del Prato; Linong Ji; Ronan Roussel; Kamlesh Khunti
Journal:  Diabetes Care       Date:  2020-06-16       Impact factor: 19.112

7.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

8.  Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.

Authors: 
Journal:  Lancet Diabetes Endocrinol       Date:  2015-09-13       Impact factor: 32.069

9.  Diabetes Risk Score in a Young Student Population in Jordan: A Cross-Sectional Study.

Authors:  Abdel-Ellah Al-Shudifat; Amjad Al-Shdaifat; Ahmad Ali Al-Abdouh; Mohammad Ibrahim Aburoman; Sara Mohammad Otoum; Amro Ghaleb Sweedan; Ibrahim Khrais; Ibrahim Hisham Abdel-Hafez; Asgeir Johannessen
Journal:  J Diabetes Res       Date:  2017-04-29       Impact factor: 4.011

10.  Characterizing the type 2 diabetes mellitus epidemic in Jordan up to 2050.

Authors:  Susanne F Awad; Peijue Huangfu; Soha R Dargham; Kamel Ajlouni; Anwar Batieha; Yousef S Khader; Julia A Critchley; Laith J Abu-Raddad
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.